200 related articles for article (PubMed ID: 29936790)
1. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
4. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
[TBL] [Abstract][Full Text] [Related]
5. The potential of cell sheet technique on the development of hepatocellular carcinoma in rat models.
Alshareeda AT; Sakaguchi K; Abumaree M; Mohd Zin NK; Shimizu T
PLoS One; 2017; 12(8):e0184004. PubMed ID: 28850615
[TBL] [Abstract][Full Text] [Related]
6. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of HCC.
Hajighasemlou S; Nikbakht M; Pakzad S; Muhammadnejad S; Gharibzadeh S; Mirmoghtadaei M; Zafari F; Seyhoun I; Ai J; Verdi J
Evid Based Complement Alternat Med; 2020; 2020():9602728. PubMed ID: 32617114
[TBL] [Abstract][Full Text] [Related]
8. Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.
Li T; Zhao S; Song B; Wei Z; Lu G; Zhou J; Huo T
Eur J Med Res; 2015 May; 20(1):56. PubMed ID: 26003220
[TBL] [Abstract][Full Text] [Related]
9. Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice.
Liu QW; Li JY; Zhang XC; Liu Y; Liu QY; Xiao L; Zhang WJ; Wu HY; Deng KY; Xin HB
J Cell Mol Med; 2020 Sep; 24(18):10525-10541. PubMed ID: 32798252
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells seldomly fuse with hepatocellular carcinoma cells and are mainly distributed in the tumor stroma in mouse models.
Li GC; Ye QH; Dong QZ; Ren N; Jia HL; Qin LX
Oncol Rep; 2013 Feb; 29(2):713-9. PubMed ID: 23232668
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
Wang H; Wang J; Shi X; Ding Y
J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
[TBL] [Abstract][Full Text] [Related]
13. Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models.
Xie C; Yang Z; Suo Y; Chen Q; Wei D; Weng X; Gu Z; Wei X
Stem Cells Transl Med; 2017 Apr; 6(4):1120-1131. PubMed ID: 28205428
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect of mesenchymal stem cells on hepatocellular carcinoma in the xenograft mice model.
Hajighasemlou S; Nikbakht M; Pakzad S; Azadbakht A; Muhammadnejad S; Mirmoghtadaei M; Gharibzadeh S; Seyhoun I; Verdi J
Vet Med Sci; 2022 Sep; 8(5):2086-2091. PubMed ID: 35838746
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
17. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo.
Zhang J; Hou L; Wu X; Zhao D; Wang Z; Hu H; Fu Y; He J
Mol Cell Biochem; 2016 May; 416(1-2):193-203. PubMed ID: 27142531
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
